BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22562364)

  • 1. Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells.
    Qiu B; Wang Y; Tao J; Wang Y
    Oncol Rep; 2012 Jul; 28(1):155-60. PubMed ID: 22562364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression levels of Fas/Fas-L mRNA in human brain glioma stem cells.
    Tao J; Qiu B; Zhang D; Wang Y
    Mol Med Rep; 2012 May; 5(5):1202-6. PubMed ID: 22344564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
    Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.
    Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J
    Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limits of CD133 as a marker of glioma self-renewing cells.
    Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
    Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting brain-tumor stem cells.
    Stupp R; Hegi ME
    Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
    [No Abstract]   [Full Text] [Related]  

  • 9. Overexpression of CD133 promotes drug resistance in C6 glioma cells.
    Angelastro JM; Lamé MW
    Mol Cancer Res; 2010 Aug; 8(8):1105-15. PubMed ID: 20663862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the proliferation and drug-resistance of human brain tumor stem-like cells.
    Qin K; Jiang X; Zou Y; Wang J; Qin L; Zeng Y
    Cell Mol Neurobiol; 2010 Aug; 30(6):955-60. PubMed ID: 20526804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of glioma cancer stem cells.
    Park DM; Rich JN
    Mol Cells; 2009 Jul; 28(1):7-12. PubMed ID: 19655094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
    Yu S; Pu P; Jiang D; An T; Guan X; Yang L
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
    Wang H; Zhang SY; Wang S; Lu J; Wu W; Weng L; Chen D; Zhang Y; Lu Z; Yang J; Chen Y; Zhang X; Chen X; Xi C; Lu D; Zhao S
    Neuro Oncol; 2009 Dec; 11(6):790-802. PubMed ID: 19289490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and culture of tumor stem cells from human brain glioma tissues].
    Huang Q; Dong J; Zhu YD; Zhang QB; Ji XY; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):331-3. PubMed ID: 17044993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.
    Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.